Piperidine

Piperidine

SCHEMBL5490582

C1CCNCC1.Cc1cccc(COCc2cccc(C)c2)c1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.51
HTR6 P50406 1/20 0.49
POLB P06746 2/20 0.45
MAOB P27338 4/20 0.44
HTR2C P28335 2/20 0.43
HTR2B P41595 1/20 0.43
TACR1 P25103 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ADRB1 P08588 1/20 0.40
MAOA P21397 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667381 0.84 IDO1 (0.69) IDO1MAOBHRH3TAAR1MAOA
Piperidine SCHEMBL5490575 0.81 POLB (0.50) IDO1HTR6POLBHTR2CHTR2B
SCHEMBL9842152 0.80 IDO1 (0.64) IDO1MAOBTAAR1MAOA
SCHEMBL9283193 0.78 TSHR (0.62) IDO1POLBMAOBTACR1TAAR1
Hydroquinone SCHEMBL10866249 0.77 IDO1 (0.60) IDO1MAOBTAAR1MAOA
SCHEMBL12266469 0.77 IDO1 (0.60) IDO1MAOBTAAR1MAOA
Metacresol SCHEMBL27664444 0.75 ACHE (0.65) POLBHTR2CADRB1
SCHEMBL8750524 0.74 IDO1 (0.62) IDO1MAOBTAAR1MAOA
SCHEMBL11019394 0.73 IDO1 (0.60) IDO1MAOBTAAR1MAOA
SCHEMBL3160721 0.73 IDO1 (0.60) IDO1MAOBHRH3TAAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151501-A1 Compounds having growth hormone releasing activity BOWERS CYRIL Y (US) 2002-10-17 US claimed
EP-1159292-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY Administrators of The Tulane Educational Fund (US) 2001-12-05 EP claimed
WO-2000009537-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2000-02-24 WO claimed
US-7250399-B2 Compounds having growth hormone releasing activity THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2007-07-31 US disclosed
US-6468974-B1 OLIGOPEPTIDES THAT PROVIDE DESIRABLE IN VITRO AND IN VIVO GROWTH HORMONE RELEASING ACTIVITY AND HAVE AT LEAST ONE OTHER DESIRABLE BIOLOGICAL ACTIVITY SUCH AS INCREASED RETENTION TIME THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND 2002-10-22 US disclosed
US-20020151501-A1 Compounds having growth hormone releasing activity BOWERS CYRIL Y (US) 2002-10-17 US disclosed
EP-1159292-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY Administrators of The Tulane Educational Fund (US) 2001-12-05 EP disclosed
WO-2000009537-A2 COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151501-A1 Compounds having growth hormone releasing activity GHSR, GHRHR, NPY1R IDO1 1831/4885HTR6 832/4885POLB 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.